Following an application from McNeil Nutritionals, submitted pursuant to Article 14(1)(a) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of plant stanol esters on blood cholesterol and the risk of coronary heart disease (Question No EFSA-Q-2008-118) [The EFSA Journal (2008) 825, 1-13.]. The claim proposed by the applicant was worded as follows: ‘By actively lowering/reducing LDL-cholesterol (by up to 14 % within 2 weeks, by blocking cholesterol absorption,) plant stanol esters reduce the risk of (coronary) heart disease’.
Recital 9, Commission Regulation (EC) No 983/2009 of 21 October 2009 on the authorisation and refus…
In forcesince 21 Oct 2009